Microbot Medical Inc. short interest in 2020
In 2020, Microbot Medical Inc.'s disclosed short interest ran from 4.31% of shares outstanding on 31 Jan 2020 to 7.04% on 31 Dec 2020, a change of +2.73 percentage points. The year's high was 8.35% on 30 Sep 2020 and its low 1.08% on 15 Apr 2020, averaging 4.27% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.22 days on 30 Oct 2020. Full history: Microbot Medical Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 4.31% (31 Jan 2020)
- End of year
- 7.04% (31 Dec 2020)
- Change
- +2.73 pp
- High
- 8.35% (30 Sep 2020)
- Low
- 1.08% (15 Apr 2020)
- Average
- 4.27%
- Highest days to cover
- 4.22 (30 Oct 2020)
- SEC filings marked
- 4
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Jan 2020 | 4.31% | 1.00 | |
| 14 Feb 2020 | 4.36% | 1.00 | |
| 28 Feb 2020 | 3.31% | 1.00 | |
| 13 Mar 2020 | 2.31% | 1.00 | |
| 31 Mar 2020 | 2.23% | 1.00 | |
| 15 Apr 2020 | 1.08% | 1.00 | 10-K filed |
| 30 Apr 2020 | 1.72% | 1.00 | |
| 15 May 2020 | 1.56% | 1.00 | 10-Q filed |
| 29 May 2020 | 1.79% | 1.00 | |
| 15 Jun 2020 | 2.32% | 1.14 | |
| 30 Jun 2020 | 2.84% | 2.10 | |
| 15 Jul 2020 | 2.86% | 1.39 | |
| 31 Jul 2020 | 2.77% | 1.76 | |
| 14 Aug 2020 | 3.80% | 1.00 | 10-Q filed |
| 31 Aug 2020 | 7.72% | 1.00 | |
| 15 Sep 2020 | 8.12% | 2.65 | |
| 30 Sep 2020 | 8.35% | 3.37 | |
| 15 Oct 2020 | 6.19% | 3.02 | |
| 30 Oct 2020 | 6.25% | 4.22 | |
| 13 Nov 2020 | 5.23% | 3.35 | |
| 30 Nov 2020 | 5.46% | 2.67 | 10-Q filed |
| 15 Dec 2020 | 6.65% | 2.99 | |
| 31 Dec 2020 | 7.04% | 3.14 |
See also: Microbot Medical Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.